Xeris Biopharma Inc.

4.17
-0.21 (-4.79%)
At close: Apr 16, 2025, 11:23 AM

Xeris Biopharma Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for XERS stock have an median target of 6, with a low estimate of 6 and a high estimate of 6.5. The median target predicts an increase of 43.88% from the current stock price of 4.17.

Target Low Average Median High
Price $6 $6.17 $6 $6.5
Change 43.88% 47.96% 43.88% 55.88%

Latest Analyst Insight Report

HC Wainwright & Co. maintains a Buy rating for Xer... Unlock content with Pro Subscription

Updated Mar 07, 2025

Rating May 24Aug 24Nov 24Jan 25Mar 25
Strong Buy 00112
Buy 21001
Hold 00101
Sell 00000
Strong Sell 00000
Total 2 1 2 1 4

Financial Forecast this Year

Revenue This Year
262.3M
from 203.07M
Increased by 29.2%
Revenue Next Year
317.64M
from 262.3M
Increased by 21.1%
EPS This Year
-0.06
from -0.37
Increased by 83.8%
EPS Next Year
0.12
from -0.06
Increased by -100%